AMP's New Zealand financial services [NZX: AMP] unit reported an 11 percent gain in underlying operating profit in 2013 as it cut costs, reduced losses from life insurance payouts and improved its general insurance margins.
The local unit of Australia's largest life insurer and fund manager said underlying profit increased to $132 million in the 12 months ended Dec. 31, from $119 million the year earlier.
Assets under management rose 10 percent to $7.8 billion from the year earlier.
The New Zealand life insurance unit narrowed its loss to $1 million from a $10 million loss the year earlier, as it paid out less claims. Funds from insurance premiums edged up 1 percent to $340 million as price rises offset lower customer retention and subdued new business sales.
Costs which the company considered were "controllable" fell to $111 million from $102 million the year earlier, excluding one-time items, it said.
AMP's New Zealand business shed client managers during the year, with 604 at Dec. 31, from 640 the year earlier. In Australia, client managers increased to 3,802 from 3,636.
Sydney-based AMP reported a 2.5 percent fall in net profit to A$672 million.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- MARKET CLOSE: NZ shares gain as market bounce continues; Kathmandu, Fletcher rise
- NZ dollar heads for 4.3% quarterly gain on TWI basis after shaking off Brexit
- Shippers prefer Firth of Thames over Manukau to replace Auckland port
- Marlborough-based wine company lists on the NXT despite OIO hiccup
- Skyline boosts profits on strong tourist growth
Most listened to
- Marlborough Wine Estates CEO Catherine Ma explains why the Chinese-owned company listed on the NXT
- National list MP Chris Bishop says Phil Twyford's accusation the government has made housing a 'race issue' is hypocritical
- Bond prices have fallen while oil prices have risen - Jason Walls explains why on Walls' Street
- NBR technology editor Chris Keall on hitting 4000 member subscribers
- In his Editor's Insight Nevil Gibson on the future of health information technology and medical devices industry